BioPactor ApS: Financial statements 2025
CVR: 43636472
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
BioPactor ApS (CVR 43636472) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 3,216,267 and a net result of DKK 527,987 compared with DKK 1,118,435 the year before. That is a decrease of 43.3% compared with the year before. The profit margin was 16.4%. Equity in the 2025 report amounted to DKK 583,290. The solvency ratio was 40%.
- Revenue
- DKK 3,216,267
- Gross Profit
- DKK 1,886,041
- Profit/Loss
- DKK 527,987
- Equity
- DKK 583,290
- Total Assets
- DKK 1,458,951
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 3.2 mio. | 1.9 mio. | 528 t. | 583 t. | - |
| 2024 | 5.7 mio. | 2.6 mio. | 1.1 mio. | 1.8 mio. | 2 |
Official annual report
How creditworthy is BioPactor ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
BioPactor ApS has published its annual report for 2024. Revenue came to DKK 5,673,940, and the net result was DKK 1,118,435.
About BioPactor ApS
BioPactor ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2022. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Mohamed Abdirashid Warsame. The company is owned by Prominent PE ApS. According to the 2024 annual report, the company had an average of 2 employees. In 2025, the company reported revenue of DKK 3,216,267 and a net result of DKK 527,987 compared with DKK 1,118,435 the year before. Equity in the 2025 report amounted to DKK 583,290.